United States · Platforms & data · The Motley Fool

Billionaire Ken Griffin Is Buying This Dividend King That Wall Street Still Rates a Buy

Published by The Motley Fool · United States 1 h ago

Despite its high price relative to earnings, AbbVie remains an attractive stock.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Broadcom Inc. $AVGO Stock Purchased by Investment House LLC

Adani Power Q2 FY27 slides: profit surges 142% on volume growth

GOAT Industries to acquire Epoxy AI customer contract revenues in C$2.8M share deal

Musk says SpaceX landed a $40 billion debt deal — and forecasts doom for some AI rivals

The Week Ahead – Can Big Tech Earnings Save the Day?

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030